APA Zitierstil

Lu, H., Yang, Y., Gad, E., Inatsuka, C., Wenner, C. A., Disis, M. L., & Standish, L. J. (2011). TLR2 agonist PSK activates human NK cells and enhances the anti-tumor effect of HER2-targeted monoclonal antibody therapy.

Chicago Zitierstil

Lu, Hailing, Yi Yang, Ekram Gad, Carol Inatsuka, Cynthia A. Wenner, Mary L. Disis, und Leanna J. Standish. TLR2 Agonist PSK Activates Human NK Cells and Enhances the Anti-tumor Effect of HER2-targeted Monoclonal Antibody Therapy. 2011.

MLA Zitierstil

Lu, Hailing, et al. TLR2 Agonist PSK Activates Human NK Cells and Enhances the Anti-tumor Effect of HER2-targeted Monoclonal Antibody Therapy. 2011.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.